Atea Pharmaceuticals
AVIR
AVIR
107 hedge funds and large institutions have $194M invested in Atea Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $188M → $194M (+$6.36M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
96% less call options, than puts
Call options by funds: $88K | Put options by funds: $2.31M
Holders
107
Holding in Top 10
1
Calls
$88K
Puts
$2.31M
Top Buyers
| 1 | +$919K | |
| 2 | +$668K | |
| 3 | +$610K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$437K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$425K |
Top Sellers
| 1 | -$603K | |
| 2 | -$435K | |
| 3 | -$285K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$236K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$186K |